About this Journal Submit a Manuscript Table of Contents 
Multiple Sclerosis International
Volume 2013 (2013), Article ID 231345, 8 pages
http://dx.doi.org/10.1155/2013/231345
Research Article

Bimonthly Evolution of Cortical Atrophy in Early Relapsing-Remitting Multiple Sclerosis over 2 Years: A Longitudinal Study

Robert Zivadinov,1 Carmen Tekwe,2 Niels Bergsland,1 Ondrej Dolezal,1,3 Eva Havrdova,3 Jan Krasensky,4 Michael G. Dwyer,1 Zdeněk Seidl,4 Deepa P. Ramasamy,1 Manuela Vaneckova,4 and Dana Horakova3

1Department of Neurology, Buffalo Neuroimaging Analysis Center, The Jacobs Neurological Institute, Buffalo, NY 14203, USA
2Department of Biostatistics, Buffalo Neuroimaging Analysis Center, Buffalo, NY 14203, USA
3Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine and General Teaching Hospital, Charles University in Prague, 121 08 Prague, Czech Republic
4Department of Radiology, First Faculty of Medicine and General Teaching Hospital, Charles University in Prague, 121 08 Prague, Czech Republic

Received 2 May 2012; Revised 1 December 2012; Accepted 15 December 2012

Academic Editor: Caterina Mainero

Copyright © 2013 Robert Zivadinov et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Zivadinov and I. Pirko, “Advances in understanding gray matter pathology in multiple sclerosis: are we ready to redefine disease pathogenesis?” BMC Neurology, vol. 12, p. 9, 2012. View at Publisher · View at Google Scholar
  2. H. E. Hulst and J. J. Geurts, “Gray matter imaging in multiple sclerosis: what have we learned?” BMC Neurology, vol. 11, no. 153, 2011. View at Publisher · View at Google Scholar
  3. B. F. Popescu and C. F. Lucchinetti, “Meningeal and cortical grey matter pathology in multiple sclerosis,” BMC Neurology, vol. 12, p. 11, 2012. View at Publisher · View at Google Scholar
  4. C. A. Walker, A. J. Huttner, and K. C. O'Connor, “Cortical injury in multiple sclerosis; the role of the immune system,” BMC Neurology, vol. 11, p. 152, 2011.
  5. M. Calabrese, N. De Stefano, M. Atzori et al., “Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis,” Archives of Neurology, vol. 64, pp. 1416–1422, 2007.
  6. J. J. G. Geurts, L. Bö, P. J. W. Pouwels, J. A. Castelijns, C. H. Polman, and F. Barkhof, “Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology,” American Journal of Neuroradiology, vol. 26, no. 3, pp. 572–577, 2005. View at Scopus
  7. A. Seewann, E. J. Kooi, S. D. Roosendaal et al., “Postmortem verification of MS cortical lesion detection with 3D DIR,” Neurology, vol. 78, no. 5, pp. 302–308, 2012. View at Publisher · View at Google Scholar
  8. A. Seewann, H. Vrenken, E. J. Kooi et al., “Imaging the tip of the iceberg: visualization of cortical lesions in multiple sclerosis,” Multiple Sclerosis, vol. 17, no. 10, pp. 1202–1210, 2011. View at Publisher · View at Google Scholar
  9. J. J. Geurts, S. D. Roosendaal, M. Calabrese et al., “Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI,” Neurology, vol. 76, pp. 418–424, 2011.
  10. M. Calabrese, M. Atzori, V. Bernardi et al., “Cortical atrophy is relevant in multiple sclerosis at clinical onset,” Journal of Neurology, vol. 254, no. 9, pp. 1212–1220, 2007. View at Publisher · View at Google Scholar
  11. M. Calabrese, F. Rinaldi, I. Mattisi et al., “The predictive value of gray matter atrophy in clinically isolated syndromes,” Neurology, vol. 77, pp. 257–263, 2011.
  12. R. G. Henry, M. Shieh, D. T. Okuda, A. Evangelista, M. L. Gorno-Tempini, and D. Pelletier, “Regional grey matter atrophy in clinically isolated syndromes at presentation,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 79, no. 11, pp. 1236–1244, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. D. P. Ramasamy, R. H. B. Benedict, J. L. Cox et al., “Extent of cerebellum, subcortical and cortical atrophy in patients with MS. A case-control study,” Journal of the Neurological Sciences, vol. 282, no. 1-2, pp. 47–54, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. S. D. Roosendaal, K. Bendfeldt, H. Vrenken et al., “Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability,” Multiple Sclerosis, vol. 17, pp. 1098–1106, 2011.
  15. N. Bergsland, D. Horakova, M. G. Dwyer et al., “Subcortical and cortical gray matter atrophy in a large sample of patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis,” AJNR American Journal of Neuroradiology, vol. 33, no. 8, pp. 1573–1578, 2012. View at Publisher · View at Google Scholar
  16. E. Fisher, J. C. Lee, K. Nakamura, and R. A. Rudick, “Gray matter atrophy in multiple sclerosis: a longitudinal study,” Annals of Neurology, vol. 64, no. 3, pp. 255–265, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. L. K. Fisniku, D. T. Chard, J. S. Jackson et al., “Gray matter atrophy is related to long-term disability in multiple sclerosis,” Annals of Neurology, vol. 64, no. 3, pp. 247–254, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Horakova, M. G. Dwyer, E. Havrdova et al., “Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis. A 5-year longitudinal study,” Journal of the Neurological Sciences, vol. 282, no. 1-2, pp. 112–119, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Valsasina, B. Benedetti, M. Rovaris, M. P. Sormani, G. Comi, and M. Filippi, “Evidence for progressive gray matter loss in patients with relapsing-remitting MS,” Neurology, vol. 65, no. 7, pp. 1126–1128, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Wegner, M. M. Esiri, S. A. Chance, J. Palace, and P. M. Matthews, “Neocortical neuronal, synaptic, and glial loss in multiple sclerosis,” Neurology, vol. 67, no. 6, pp. 960–967, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. J. W. Peterson, L. Bö, S. Mörk, A. Chang, and B. D. Trapp, “Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions,” Annals of Neurology, vol. 50, no. 3, pp. 389–400, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Calabrese and P. Gallo, “Magnetic resonance evidence of cortical onset of multiple sclerosis,” Multiple Sclerosis, vol. 15, no. 8, pp. 933–941, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. O. Dolezal, M. G. Dwyer, D. Horakova et al., “Detection of cortical lesions is dependent on choice of slice thickness in patients with multiple sclerosis,” International Review of Neurobiology, vol. 79, pp. 475–489, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Kutzelnigg and H. Lassmann, “Cortical lesions and brain atrophy in MS,” Journal of the Neurological Sciences, vol. 233, no. 1-2, pp. 55–59, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. E. Havrdova, R. Zivadinov, J. Krasensky et al., “Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis,” Multiple Sclerosis, vol. 15, no. 8, pp. 965–976, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Horakova, J. L. Cox, E. Havrdova et al., “Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 79, no. 4, pp. 407–414, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Kalincik, D. Horakova, O. Dolezal et al., “Interferon, azathioprine and corticosteroids in multiple sclerosis: 6-year follow-up of the ASA cohort,” Clinical Neurology and Neurosurgery, vol. 114, pp. 940–946, 2012.
  28. R. Zivadinov, M. Heininen-Brown, C. V. Schirda et al., “Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: a case-control study,” Neuroimage, vol. 59, no. 1, pp. 331–339, 2012. View at Publisher · View at Google Scholar
  29. S. M. Smith, Y. Zhang, M. Jenkinson et al., “Accurate, robust, and automated longitudinal and cross-sectional brain change analysis,” NeuroImage, vol. 17, no. 1, pp. 479–489, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Diggle, Analysis of Longitudinal Data, Oxford University Press, Oxford, UK, 2nd edition, 2002.
  31. J. H. Simon, L. D. Jacobs, M. Campion et al., “Magnetic resonance studies of intramuscular interferon β-1a for relapsing multiple sclerosis,” Annals of Neurology, vol. 43, no. 1, pp. 79–87, 1998. View at Publisher · View at Google Scholar · View at Scopus
  32. L. D. Jacobs, D. L. Cookfair, R. A. Rudick et al., “Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis,” Annals of Neurology, vol. 39, no. 3, pp. 285–294, 1996. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Nakamura, R. A. Rudick, J.-C. Lee, P. Foulds, and E. Fisher, “Effect of intramuscular interferon beta-1a on gray matter atrophy in relapsing-remitting multiple sclerosis,” Neurology, vol. 74, p. A407, 2010.
  34. R. A. Rudick, E. Fisher, J. C. Lee, J. T. Duda, and J. Simon, “Brain atrophy in relapsing multiple sclerosis: relationship to relapses, EDSS, and treatment with interferon βla,” Multiple Sclerosis, vol. 6, no. 6, pp. 365–372, 2000. View at Publisher · View at Google Scholar · View at Scopus
  35. R. A. Rudick, E. Fisher, J. C. Lee, J. Simon, and L. Jacobs, “Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS,” Neurology, vol. 53, no. 8, pp. 1698–1704, 1999. View at Scopus
  36. R. Zivadinov, L. Locatelli, D. Cookfair et al., “Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy,” Multiple Sclerosis, vol. 13, no. 4, pp. 490–501, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Zivadinov, A. T. Reder, M. Filippi et al., “Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis,” Neurology, vol. 71, no. 2, pp. 136–144, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Calabrese, F. Agosta, F. Rinaldi et al., “Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis,” Archives of Neurology, vol. 66, no. 9, pp. 1144–1150, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. R. H. B. Benedict, J. M. Bruce, M. G. Dwyer et al., “Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis,” Archives of Neurology, vol. 63, no. 9, pp. 1301–1306, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. M. P. Amato, M. L. Bartolozzi, V. Zipoli et al., “Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment,” Neurology, vol. 63, no. 1, pp. 89–93, 2004. View at Scopus